Publications
Detailed Information
Imbalance of Th17 to Th1 cells in Behcet`s disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, J. | - |
dc.contributor.author | Park, J. A. | - |
dc.contributor.author | Lee, E. Y. | - |
dc.contributor.author | Lee, Y. J. | - |
dc.contributor.author | Lee, E. B. | - |
dc.contributor.author | Song, Y. W. | - |
dc.date.accessioned | 2012-06-26T05:45:42Z | - |
dc.date.available | 2012-06-26T05:45:42Z | - |
dc.date.issued | 2010-08 | - |
dc.identifier.citation | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY; Vol.28 4; S16-S19 | ko_KR |
dc.identifier.issn | 0392-856X | - |
dc.identifier.uri | https://hdl.handle.net/10371/77438 | - |
dc.description.abstract | Objectives. Behcet`s disease (BD) is a helper T cell-mediated autoimmune disease characterised by recurrent oro-genital ulcers, uveitis and skin lesions. The helper T cells are divided into Th1, Th2 and Th17 cells according to the pattern of cytokine secretion. Th1 and Th17 cells can contribute to the development of the disease with their respective proinflammatory cytokines, IFN-gamma and IL-17. In this study, we investigated the relative role of Th17, Th1 and Th2 cells in BD. Methods. Peripheral blood mononuclear cells were isolated from 30 patients with BD, for whom the detailed clinical manifestations and medication history were investigated and recorded. Surface markers and intracellular levels of IL-17, IFN-gamma and IL-4 in isolated CD4(+) T cells were measured using flow-cytometry from these patients and from two control groups, 34 rheumatoid arthritis patients and 24 healthy blood donors to analyse the relationship of Th1, Th17 and Th2 cells in BD. Results. The ratio of Th17/Th1 cells was significantly increased in BD compared to healthy controls (0.16 +/- 0.09 vs. 0.10 +/- 0.04, p=0.012), while there was no difference in the ratios of Th1/Th2 or Th17/Th2 cells. Th17/Th1 ratio was elevated in BD patients with uveitis or folliculitis compared to those without it (0.21 +/- 0.10 vs. 0.13 +/- 0.06, p=0.045 for uveitis; 0.18 +/- 0.10 vs. 0.12 +/- 0.05, p=0.036 for folliculitis). Conclusion. Our results confirm that TH17 cells are instrumental in Behcet`s uveitis and folliculitis. Furthermore, our findings suggest that the role of Th17 cells should be interpreted in the context of their ratio to Th1 cells. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | CLINICAL & EXPER RHEUMATOLOGY | ko_KR |
dc.subject | Behcet`s syndrome | ko_KR |
dc.subject | flow cytometry | ko_KR |
dc.subject | interferon | ko_KR |
dc.subject | interleukin-17 | ko_KR |
dc.subject | uveitis | ko_KR |
dc.title | Imbalance of Th17 to Th1 cells in Behcet`s disease | ko_KR |
dc.type | Article | ko_KR |
dc.citation.journaltitle | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | - |
dc.description.citedreference | MIOSSEC P, 2009, MICROBES INFECT | - |
dc.description.citedreference | Mauermann N, 2008, AM J RESP CRIT CARE, V178, P379, DOI 10.1164/rccm.200711-1648OC | - |
dc.description.citedreference | Chi W, 2008, INVEST OPHTH VIS SCI, V49, P3058, DOI 10.1167/iovs.07-1390 | - |
dc.description.citedreference | Mumcu G, 2008, CLIN EXP RHEUMATOL, V26, pS121 | - |
dc.description.citedreference | Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004 | - |
dc.description.citedreference | Lew W, 2008, BRIT J DERMATOL, V158, P505, DOI 10.1111/j.1365-2133.2007.08403.x | - |
dc.description.citedreference | Krause I, 2008, CURR OPIN RHEUMATOL, V20, P82 | - |
dc.description.citedreference | Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397 | - |
dc.description.citedreference | Nakae S, 2007, J LEUKOCYTE BIOL, V81, P1258, DOI 10.1186/jlb.1006610 | - |
dc.description.citedreference | Cruz A, 2006, J IMMUNOL, V177, P1416 | - |
dc.description.citedreference | Zouboulis CC, 2006, J INVEST DERMATOL, V126, P1444, DOI 10.1038/sj.jid.5700281 | - |
dc.description.citedreference | Sergejeva S, 2005, AM J RESP CELL MOL, V33, P248, DOI 10.1165/rcmb.2004-0213OC | - |
dc.description.citedreference | Nagafuchi H, 2005, CLIN EXP IMMUNOL, V139, P363, DOI 10.1111/j.1365-2249.2004.02688.x | - |
dc.description.citedreference | Fukushima A, 2005, CURR EYE RES, V30, P7, DOI 10.1080/02713680490522461 | - |
dc.description.citedreference | Houman A, 2004, J AUTOIMMUN, V23, P267, DOI 10.1016/j.just.2004.07.005 | - |
dc.description.citedreference | Kolls JK, 2004, IMMUNITY, V21, P467 | - |
dc.description.citedreference | Ben Ahmed M, 2004, ARTHRITIS RHEUM, V50, P2291, DOI 10.1002/art.20334 | - |
dc.description.citedreference | Aridogan BC, 2003, J DERMATOL, V30, P602 | - |
dc.description.citedreference | Hirohata S, 2003, ARTHRITIS RES THER, V5, P139, DOI 10.1186/ar757 | - |
dc.description.citedreference | Psarra K, 2003, ADV EXP MED BIOL, V528, P249 | - |
dc.description.citedreference | Tunc R, 2002, J RHEUMATOL, V29, P2393 | - |
dc.description.citedreference | Hamzaoui K, 2002, SCAND J RHEUMATOL, V31, P205 | - |
dc.description.citedreference | Gul A, 2001, CLIN EXP RHEUMATOL, V19, pS6 | - |
dc.description.citedreference | Eksioglu-Demiralp E, 2001, CLIN EXP RHEUMATOL, V19, pS19 | - |
dc.description.citedreference | Kobayashi M, 2000, HISTOPATHOLOGY, V36, P362 | - |
dc.description.citedreference | Frassanito MA, 1999, ARTHRITIS RHEUM, V42, P1967 | - |
dc.description.citedreference | Krause I, 1999, CLIN EXP RHEUMATOL, V17, P347 | - |
dc.description.citedreference | Laan M, 1999, J IMMUNOL, V162, P2347 | - |
dc.description.citedreference | CASPI RR, 1994, J IMMUNOL, V152, P890 | - |
dc.description.citedreference | MAHRLE G, 1990, J INVEST DERMATOL, V95, pS132 | - |
dc.description.citedreference | 1990, LANCET, V335, P1078 | - |
dc.description.citedreference | ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315 | - |
dc.description.tc | 4 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.